{"id":342503,"date":"2026-11-07T19:41:46","date_gmt":"2026-11-07T14:11:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/brooks-laboratories-q2-results-fy27-pat-68-crore\/"},"modified":"2026-11-07T19:41:46","modified_gmt":"2026-11-07T14:11:46","slug":"brooks-laboratories-q2-results-fy27-pat-68-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/brooks-laboratories-q2-results-fy27-pat-68-crore\/","title":{"rendered":"Brooks Laboratories Q2 Results FY27: PAT Jumps 747.24% to Rs 67.61 Cr, Revenue Rs 19.25 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Brooks Laboratories Q2 Results FY27 were declared on 7 November 2026 on a consolidated basis. Revenue was Rs 19.25 Cr, down 17.91% YoY from Rs 23.45 Cr, while net profit rose 747.24% to Rs 67.61 Cr from Rs 7.98 Cr. The quarterly results also show Operating Profit of Rs 0.32 Cr against Rs 2.52 Cr a year earlier. YoY growth therefore split sharply between the top line and the bottom line.<\/p>\n<\/div>\n

Brooks Laboratories Ltd<\/a> (BROOKS) Q2 Results FY27 announced on 7 November 2026, covering the company’s financial performance for the July to September quarter. In Brooks Laboratories Q2 Results FY27, revenue came in at Rs 19.25 Cr and PAT at Rs 67.61 Cr. The results date of 7 November 2026 applies to these consolidated results, which compare the quarter with the same period of last year.<\/p>\n

This Brooks Laboratories Q2 Results coverage works through the numbers in a fixed order. The results analysis moves from financial highlights to business drivers, then to outlook and risks, and the reader can follow each figure back to the table below.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n